Virtus ETF Advisers LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $56,680 - $69,894	3,215 Added 16.8%	22,347 $440,000
Q4 2023 Feb 15, 2024	BUY	$14.37 - $19.07 $9,642 - $12,795	671 Added 3.63%	19,132 $335,000
Q3 2023 Nov 07, 2023	SELL	$13.62 - $20.2 $32,551 - $48,278	-2,390 Reduced 11.46%	18,461 $320,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $12,058 - $19,034	1,155 Added 5.86%	20,851 $293,000
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $3,755 - $5,542	351 Added 1.81%	19,696 $211,000
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $103,488 - $154,507	-9,062 Reduced 31.9%	19,345 $289,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $4,050 - $5,565	415 Added 1.48%	28,407 $365,000
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $15,420 - $23,150	-2,029 Reduced 6.76%	27,992 $271,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $124 - $181	12 Added 0.04%	30,021 $353,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $31,356 - $44,681	-2,753 Reduced 8.4%	30,009 $342,000
Q2 2021 Aug 10, 2021	BUY	$13.22 - $19.09 $229,340 - $331,173	17,348 Added 112.55%	32,762 $456,000
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $4,436 - $6,376	266 Added 1.76%	15,414 $285,000
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $12,298 - $17,575	831 Added 5.8%	15,148 $268,000
Q3 2020 Nov 13, 2020	SELL	$15.21 - $25.53 $29,765 - $49,962	-1,957 Reduced 12.03%	14,317 $219,000
Q2 2020 Aug 05, 2020	BUY	$15.08 - $26.0 $245,411 - $423,124	16,274 New	16,274 $415,000
Q2 2019 Aug 13, 2019	SELL	$13.2 - $20.39 $155,271 - $239,847	-11,763 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$15.93 - $26.59 $28,243 - $47,144	-1,773 Reduced 13.1%	11,763 $212,000
Q4 2018 Feb 05, 2019	BUY	$16.25 - $28.09 $219,960 - $380,226	13,536 New	13,536 $380,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account